Ken Keyong Ren - Net Worth and Insider Trading

Ken Keyong Ren Net Worth

The estimated net worth of Ken Keyong Ren is at least $8,400 dollars as of 2024-11-13. Ken Keyong Ren is the CEO and Director of CASI Pharmaceuticals Inc and owns about 1,500 shares of CASI Pharmaceuticals Inc (CASI) stock worth over $8,400. Details can be seen in Ken Keyong Ren's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ken Keyong Ren has not made any transactions after 2016-01-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ken Keyong Ren

To

Ken Keyong Ren Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ken Keyong Ren owns 1 companies in total, including CASI Pharmaceuticals Inc (CASI) .

Click here to see the complete history of Ken Keyong Ren’s form 4 insider trades.

Insider Ownership Summary of Ken Keyong Ren

Ticker Comapny Transaction Date Type of Owner
CASI CASI Pharmaceuticals Inc 2016-01-19 Chief Executive Officer

Ken Keyong Ren Latest Holdings Summary

Ken Keyong Ren currently owns a total of 1 stock. Ken Keyong Ren owns 1,500 shares of CASI Pharmaceuticals Inc (CASI) as of January 19, 2016, with a value of $8,400.

Latest Holdings of Ken Keyong Ren

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CASI CASI Pharmaceuticals Inc 2016-01-19 1,500 5.60 8,400

Holding Weightings of Ken Keyong Ren


Ken Keyong Ren Form 4 Trading Tracker

According to the SEC Form 4 filings, Ken Keyong Ren has made a total of 0 transactions in CASI Pharmaceuticals Inc (CASI) over the past 5 years. The most-recent trade in CASI Pharmaceuticals Inc is the acquisition of 1,500 shares on January 19, 2016, which cost Ken Keyong Ren around $10,950.

Insider Trading History of Ken Keyong Ren

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ken Keyong Ren Trading Performance

GuruFocus tracks the stock performance after each of Ken Keyong Ren's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ken Keyong Ren is 73.24%. GuruFocus also compares Ken Keyong Ren's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ken Keyong Ren within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ken Keyong Ren's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ken Keyong Ren

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 25.35 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 23.41 LIMIT LIMIT LIMIT LIMIT LIMIT

Ken Keyong Ren Ownership Network

Ownership Network List of Ken Keyong Ren

No Data

Ownership Network Relation of Ken Keyong Ren

Insider Network Chart

Ken Keyong Ren Owned Company Details

What does CASI Pharmaceuticals Inc do?

Who are the key executives at CASI Pharmaceuticals Inc?

Ken Keyong Ren is the Chief Executive Officer of CASI Pharmaceuticals Inc. Other key executives at CASI Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO Wei-wu He , Chief Financial Officer Weihao Xu , and President Larry Zhang .

CASI Pharmaceuticals Inc (CASI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CASI Pharmaceuticals Inc (CASI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CASI Pharmaceuticals Inc (CASI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CASI Pharmaceuticals Inc (CASI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CASI Pharmaceuticals Inc Insider Transactions

No Available Data

Ken Keyong Ren Mailing Address

Above is the net worth, insider trading, and ownership report for Ken Keyong Ren. You might contact Ken Keyong Ren via mailing address: 9640 Medical Center Drive, Rockville Md 20850.